European Pharmaceutical analytical testing outsourcing Market 2026-2035

Description

List of Tables

European Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report by Product Type (API, Raw Materials, and Finished products), By Services (Bioanalytical services, Stability testing, Drug substance, Method development & Validation, and Others), Forecast Period (2026-2035)

Industry Overview

European pharmaceutical analytical testing outsourcing market was valued at $2,544.7 million in 2025 and is projected to reach $4,912.0 million by 2035, growing at a CAGR of 6.8% during the forecast period (2026-2035). The European pharmaceutical analytical testing outsourcing market is growing due to the rising complexity of drug development and the stringent regulatory requirements imposed by the EMA. Companies such as ICON plc and Eurofins Scientific SE are actively expanding their service portfolios to include comprehensive analytical testing for APIs, excipients, and finished products. Outsourcing helps pharmaceutical firms reduce operational costs, maintain high-quality standards, and expedite time-to-market for new therapies. The integration of advanced instrumentation and automated workflows by leading providers further strengthens market adoption. The ongoing focus on efficiency, accuracy, and regulatory compliance is sustaining long-term market expansion.

Market Dynamics

Rising Demand for Method Development and Validation Services

The European pharmaceutical analytical testing outsourcing market is increasingly driven by the need for method development and validation services. Pharmaceutical companies are outsourcing these specialized functions to ensure robust, reproducible, and regulatory-compliant analytical methods. For instance, Charles River Laboratories International, Inc. provides method validation and development services to support complex drug molecules. Covance Inc. also offers tailored method development solutions for both small molecules and biologics. Outsourcing these activities helps companies reduce timelines and optimize in-house resources. Consequently, the emphasis on high-quality analytical method support continues to expand market adoption.

Expansion of Stability Testing Services

Another notable trend is the growth of stability testing services across Europe, fueled by stringent regulatory requirements and the launch of new drug formulations. Stability testing ensures that pharmaceutical products maintain efficacy, safety, and quality over time. Companies like Labcorp Drug Development specialize in long-term and accelerated stability testing for various dosage forms. Frontage Laboratories, Inc. also provides comprehensive stability assessment services, enabling manufacturers to meet global compliance standards. Outsourcing stability studies allows organizations to leverage specialized expertise and sophisticated infrastructure. This trend is contributing significantly to the market's steady growth across the region.

Market Segmentation

Based on the product type, the market is segmented into API, raw materials, and finished products.
Based on the application, the market is segmented into bioanalytical services, stability testing, drug substance, method development & validation, and others.

Finished Products Segment to Lead the Market with the Largest Share

The European pharmaceutical analytical testing outsourcing market is witnessing notable growth driven by the increasing demand for finished product analysis. Pharmaceutical companies are prioritizing outsourcing to ensure regulatory compliance and maintain product quality. For example, Eurofins Scientific SE provides comprehensive testing for finished formulations, including potency, stability, and safety assessments. SGS S.A. also delivers specialized analytical services for evaluating final drug products across multiple dosage forms. By leveraging these external capabilities, manufacturers can accelerate product launches while minimizing in-house resource requirements. This focus on outsourced finished product testing continues to shape market expansion across Europe.

Bioanalytical Services: A Key Segment in Market Growth

The market is also expanding due to the rising adoption of bioanalytical services for clinical trials and pharmacokinetic evaluations. Outsourced bioanalytical testing offers precise measurement of drug concentrations, biomarker analysis, and immunogenicity assessment. Companies such as Intertek Group plc provide these services to support early-stage and late-phase drug development. Almac Group Ltd similarly offers high-throughput bioanalytical solutions for clinical programs, enabling faster regulatory submissions. The complexity of modern biologics and personalized therapies has strengthened reliance on specialized external laboratories. As a result, bioanalytical services have become a major driver of the European analytical testing outsourcing market.

Regional Outlook

European pharmaceutical analytical testing outsourcing market is further divided by countries, including the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe.

Germany Dominates the Market with a Major Share

The German pharmaceutical analytical testing outsourcing market is witnessing growth driven by increased clinical trial activities and stringent quality regulations. Providers like SGS S.A. and Eurofins Scientific SE are offering specialized analytical testing services, including method development, validation, and stability testing. Germany's robust pharmaceutical sector, coupled with the emphasis on adherence to EU GMP standards, encourages outsourcing solutions for both small molecules and biologics. Companies are leveraging these outsourced services to optimize operational efficiency while ensuring regulatory compliance. This trend underscores Germany's strategic role in shaping the European outsourcing landscape.

Market Players Outlook

The major companies operating in the European pharmaceutical analytical testing outsourcing market include Eurofins Scientific SE, SGS S.A., Intertek Group plc, Almac Group Ltd, and ICON plc, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Development

In August 2025, West Pharmaceutical Services opened a new analytical laboratory in Stolberg, Germany, relocating and expanding its services from Eschweiler to enhance analytical chemistry and microbiological testing for injectable drug containment and delivery. The purpose-built facility employs approximately 80 specialists, focuses on expanded method validation and automation, and adheres to stringent regulatory requirements like EU GMP Annexe 1, providing enhanced contract services to customers.

The Report Covers:

Market value data analysis of 2025 and forecast to 2035.
Annualised market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the European pharmaceutical analytical testing outsourcing market. Based on the availability of data, information related to new products and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying 'who-stands-where' in the market.

Product Code: OMR2023660

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
European Pharmaceutical Analytical Testing Outsourcing Market Sales Analysis - Product Type | Services | ($ Million)
European Pharmaceutical Analytical Testing Outsourcing Market Sales Performance of Top Countries
1.1. Research Methodology
Primary Research Approach
Secondary Research Approach
1.2. Market Snapshot

2. Market Overview and Insights

2.1. Scope of the Study
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key European Pharmaceutical Analytical Testing Outsourcing Industry Trends
- 2.2.2. Market Recommendations

3. Market Determinants

3.1. Market Drivers
- 3.1.1. Drivers For European Pharmaceutical Analytical Testing Outsourcing Market: Impact Analysis
3.2. Market Pain Points and Challenges
- 3.2.1. Restraints For European Pharmaceutical Analytical Testing Outsourcing Market: Impact Analysis
3.3. Market Opportunities

4. Competitive Landscape

4.1. Competitive Dashboard - European Pharmaceutical Analytical Testing Outsourcing Market Revenue and Share by Manufacturers
Pharmaceutical Analytical Testing Outsourcing Product Comparison Analysis
Top Market Player Ranking Matrix
4.2. Key Company Analysis
- 4.2.1. Almac Group Ltd.
  - 4.2.1.1. Overview
  - 4.2.1.2. Product Portfolio
  - 4.2.1.3. Financial Analysis
  - 4.2.1.4. SWOT Analysis
  - 4.2.1.5. Business Strategy
- 4.2.2. Eurofins Scientific SE
  - 4.2.2.1. Overview
  - 4.2.2.2. Product Portfolio
  - 4.2.2.3. Financial Analysis
  - 4.2.2.4. SWOT Analysis
  - 4.2.2.5. Business Strategy
- 4.2.3. ICON plc
  - 4.2.3.1. Overview
  - 4.2.3.2. Product Portfolio
  - 4.2.3.3. Financial Analysis
  - 4.2.3.4. SWOT Analysis
  - 4.2.3.5. Business Strategy
- 4.2.4. Intertek Group plc
  - 4.2.4.1. Overview
  - 4.2.4.2. Product Portfolio
  - 4.2.4.3. Financial Analysis
  - 4.2.4.4. SWOT Analysis
  - 4.2.4.5. Business Strategy
- 4.2.5. SGS S.A.
  - 4.2.5.1. Overview
  - 4.2.5.2. Product Portfolio
  - 4.2.5.3. Financial Analysis
  - 4.2.5.4. SWOT Analysis
  - 4.2.5.5. Business Strategy
4.3. Top Winning Strategies by Market Players
- 4.3.1. Merger and Acquisition
- 4.3.2. Product Launch
- 4.3.3. Partnership And Collaboration

5. European Pharmaceutical Analytical Testing Outsourcing Market Sales Analysis by Product Type ($ Million)

5.1. API
5.2. Raw Materials
5.3. Finished products

6. European Pharmaceutical Analytical Testing Outsourcing Market Sales Analysis by Services ($ Million)

6.1. Bioanalytical services
6.2. Stability testing
6.3. Drug substance
6.4. Method development & Validation
6.5. Others (Quality Testing)

7. Regional Analysis

7.1. European Pharmaceutical Analytical Testing Outsourcing Market Sales Analysis - Product Type | Services | Country ($ Million)
Macroeconomic Factors for Europe
- 7.1.1. UK
- 7.1.2. Germany
- 7.1.3. Italy
- 7.1.4. Spain
- 7.1.5. France
- 7.1.6. Russia
- 7.1.7. Rest of Europe

8. Company Profiles

8.1. Almac Group Ltd.
- 8.1.1. Quick Facts
- 8.1.2. Company Overview
- 8.1.3. Product Portfolio
- 8.1.4. Business Strategies
8.2. Anapharm Bioanalytics Inc.
- 8.2.1. Quick Facts
- 8.2.2. Company Overview
- 8.2.3. Product Portfolio
- 8.2.4. Business Strategies
8.3. BioReliance Corp.
- 8.3.1. Quick Facts
- 8.3.2. Company Overview
- 8.3.3. Product Portfolio
- 8.3.4. Business Strategies
8.4. CellCarta Inc.
- 8.4.1. Quick Facts
- 8.4.2. Company Overview
- 8.4.3. Product Portfolio
- 8.4.4. Business Strategies
8.5. ClinChoice, Inc.
- 8.5.1. Quick Facts
- 8.5.2. Company Overview
- 8.5.3. Product Portfolio
- 8.5.4. Business Strategies
8.6. Element Materials Technology Ltd
- 8.6.1. Quick Facts
- 8.6.2. Company Overview
- 8.6.3. Product Portfolio
- 8.6.4. Business Strategies
8.7. Eurofins Scientific SE
- 8.7.1. Quick Facts
- 8.7.2. Company Overview
- 8.7.3. Product Portfolio
- 8.7.4. Business Strategies
8.8. Evotec SE
- 8.8.1. Quick Facts
- 8.8.2. Company Overview
- 8.8.3. Product Portfolio
- 8.8.4. Business Strategies
8.9. GalChimia SL
- 8.9.1. Quick Facts
- 8.9.2. Company Overview
- 8.9.3. Product Portfolio
- 8.9.4. Business Strategies
8.10. ICON plc
- 8.10.1. Quick Facts
- 8.10.2. Company Overview
- 8.10.3. Product Portfolio
- 8.10.4. Business Strategies
8.11. Intertek Group plc
- 8.11.1. Quick Facts
- 8.11.2. Company Overview
- 8.11.3. Product Portfolio
- 8.11.4. Business Strategies
8.12. KCAS Bioanalytical & Biomarker Services Ltd
- 8.12.1. Quick Facts
- 8.12.2. Company Overview
- 8.12.3. Product Portfolio
- 8.12.4. Business Strategies
8.13. KYMOS Group AG
- 8.13.1. Quick Facts
- 8.13.2. Company Overview
- 8.13.3. Product Portfolio
- 8.13.4. Business Strategies
8.14. Merck KGaA
- 8.14.1. Quick Facts
- 8.14.2. Company Overview
- 8.14.3. Product Portfolio
- 8.14.4. Business Strategies
8.15. SGS Societe Generale de Surveillance SA
- 8.15.1. Quick Facts
- 8.15.2. Company Overview
- 8.15.3. Product Portfolio
- 8.15.4. Business Strategies
8.16. Sofpromed s.r.o.
- 8.16.1. Quick Facts
- 8.16.2. Company Overview
- 8.16.3. Product Portfolio
- 8.16.4. Business Strategies
8.17. Syneos Health, Inc.
- 8.17.1. Quick Facts
- 8.17.2. Company Overview
- 8.17.3. Product Portfolio
- 8.17.4. Business Strategies
8.18. TCI Laboratories Ltd
- 8.18.1. Quick Facts
- 8.18.2. Company Overview
- 8.18.3. Product Portfolio
- 8.18.4. Business Strategies
8.19. ViviaBiotech S.L.
- 8.19.1. Quick Facts
- 8.19.2. Company Overview
- 8.19.3. Product Portfolio
- 8.19.4. Business Strategies
8.20. Worldwide Clinical Trials, Inc.
- 8.20.1. Quick Facts
- 8.20.2. Company Overview
- 8.20.3. Product Portfolio
- 8.20.4. Business Strategies